Filing Details
- Accession Number:
- 0000905193-10-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-19 13:00:00
- Reporting Period:
- 2010-05-17
- Filing Date:
- 2010-05-19
- Accepted Time:
- 2010-05-19 18:06:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
275053 | Natures Sunshine Products Inc | NATR | Pharmaceutical Preparations (2834) | 870327982 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
905193 | K Candace Weir | 9 Elk St Albany NY 12207 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-05-17 | 2,800 | $12.50 | 1,411,404 | No | 4 | S | Indirect | By Paradigm Capital Management |
Common Stock | Disposition | 2010-05-18 | 7,447 | $12.51 | 1,403,957 | No | 4 | S | Indirect | By Paradigm Capital Management |
Common Stock | Disposition | 2010-05-19 | 500 | $12.50 | 1,403,457 | No | 4 | S | Indirect | By Paradigm Capital Management |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Paradigm Capital Management |
No | 4 | S | Indirect | By Paradigm Capital Management |
No | 4 | S | Indirect | By Paradigm Capital Management |
Footnotes
- The shares are beneficially owned by Paradigm Capital Management, Inc. ("Paradigm"), which has sole voting and dispositive power over the shares. As a director and president of Paradigm, Ms. Weir may be deemed to beneficially own, and to have sole voting and dispositive power over, such shares. Ms. Weir disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.58, inclusive. The reporting person undertakes to provide Nature's Sunshine Products, Inc., any security holder of Nature's Sunshine Products, Inc., or the staff of the Securities and Exchange Commision, on request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.